Over the course of his career, healthcare investor and entrepreneur Dr. Harry Stylli has provided executive leadership to numerous innovative companies. Dr. Harry Stylli currently serves as chairman of OncoCellMDx, a privately held diagnostic testing developer. Using technologies created internally and licensed through Harvard Medical School, the company has created non-invasive blood-based tests to evaluate a cancer’s grade and level of aggression.. Continue Reading.
Ulcerative colitis is characterized by inflammation in the lower gastrointestinal track and the development of open sores and/or ulcers within the large intestine. Although onset is most common between the ages of 15 and 30 years, the disorder can develop at any age. People with ulcerative colitis experience occasional flareups, followed by periods of remission.… Continue Reading
Genome sequencing is growing more affordable, but what can our genes really tell us about our likelihood of developing diseases like cancer? Continue Reading
What are living drugs? How are living drugs developed? We examine this treatment and its life-saving potential to fight diseases such as cancer. Continue Reading
What are living drugs? How are living drugs developed? We examine this treatment and its life-saving potential to fight diseases such as cancer. Continue Reading
A look at the ENCODE Project, the role of coding and noncoding DNA, and how data revealed by ENCODE could help researchers cure cancer. Continue Reading
Scientific studies reveal that free radicals can have positive as well as negative health implications. We explore the findings of recent research. Continue Reading
Genome sequencing is growing more affordable, but what can our genes really tell us about our likelihood of developing diseases like cancer? Continue Reading
What are living drugs? How are living drugs developed? We examine this treatment and its life-saving potential to fight diseases such as cancer. Continue Reading
Scientific studies reveal that free radicals can have positive as well as negative health implications. We explore the findings of recent research. Continue Reading
A look at the ENCODE Project, the role of coding and noncoding DNA, and how data revealed by ENCODE could help researchers cure cancer. Continue Reading
The 100,000 Genomes Project is a British initiative led by the National Health Service (NHS). In this article we explore the project’s main aims and how data gathered could increase our scientific understanding of a wide range of diseases, from rare genetic disorders to cancer. What is the aim of the 100,000 Genomes Project? The… Continue Reading
We explore the development of genetically-engineered insulin and its importance in treating an estimated 100 million Americans who have diabetes. Continue Reading